PRENW
Prenetics Holding Company LimitedNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-11.04
Beta
0.15
52W High
$0.07
52W Low
$0.01
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-40.80%
Forward P/E
—
PEG Ratio
—
About Prenetics Holding Company Limited
Prenetics Holding Company Limited is a leading global healthcare technology firm focused on improving health outcomes through cutting-edge genetic testing and digital health solutions. The company provides a robust portfolio of genetic screening and diagnostics services, leveraging advanced technologies and data analytics to promote personalized medicine and actionable health insights. With the expanding demand for precision health solutions, Prenetics is well-positioned to capitalize on emerging opportunities in a dynamic, data-driven healthcare landscape, making it a promising contender for institutional investors seeking growth in the health tech sector.
Fundamentals
| Revenue (TTM) | $92.39M |
| Gross Profit (TTM) | $48.79M |
| EBITDA | $-37.19M |
| Operating Margin | -37.20% |
| Return on Equity | -22.10% |
| Return on Assets | -11.40% |
| Revenue/Share (TTM) | $6.58 |
| Book Value | $9.76 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 248.60% |
| Shares Outstanding | 0 |
| Float | $11.92M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
54.75%
HV 20-Day
189.18%
HV 30-Day
159.55%
HV 60-Day
118.61%
HV Rank
—
Volatility is currently contracting
Data last updated: 5/25/2026